Ertapenem for injection may be administered by intravenous infusion for up to 14 days or intramuscular injection for up to 7 days. When administered ...
Ertapenem for injection may be administered by intravenous infusion for up to 14 days or intramuscular injection for up to 7 days. When administered ...
The Company's main products are broad-acting antibiotics meropenem and ertapenem, which are used to fight severe clinical infections. The Company also ...
U.S. Food and Drug Administration (FDA) approved Savior's ANDA of Ertapenem 1g in Mar, 2019. 2017.08.17/. Savior Lifetec Co., Ltd. - Investor Conference 2017.
2014年5月20日 — The present invention relates to an efficient process of synthesizing some known Ertapenem compounds and to provide new intermediate compounds ...